Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05810194 · ClinicalTrials.gov registry record
Retrospective Cohort Study Comparing a Novel Gel Dressing vs SoC in the Treatment of Radiation Dermatitis
A clinical trial, sponsored by Stratpharma.
- Completed
- Registry status
- 344
- Enrollment target
NCT05810194 is a clinical trial that has completed, run by Stratpharma. The registered enrollment target is 344 participants.
The verdict
NCT05810194 has completed, sponsored by Stratpharma.
- COMPLETED
- Registry status
- 344 participants
- Enrollment target
Study Summary
Routinely collected data on radiation-induced skin toxicity from 2010 to 2022 will be retrospectively analyzed. Data will be split into two cohorts: patients that received 1) StrataXRT and 2) standard of care. The incidence of grade ≥ 2 radiation dermatitis, the time to onset of grade ≥ 2 radiation dermatitis, the radiation dose at onset of grade ≥ 2 radiation dermatitis, the incidence of moist desquamation and the number of treatment interruptions will be compared between the cohorts.
Interventions
- DRUG Aquaphor
- DEVICE StrataXRT
- DRUG Calendula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 344 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2023-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05810194
The ClinicalTrials.gov registry entry for NCT05810194 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 344 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stratpharma, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Aquaphor is the first listed.
NCT05810194 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05810194 about?
NCT05810194 is a clinical study titled "Retrospective Cohort Study Comparing a Novel Gel Dressing vs SoC in the Treatment of Radiation Dermatitis". Routinely collected data on radiation-induced skin toxicity from 2010 to 2022 will be retrospectively analyzed. Data will be split into two cohorts: patients that received 1) StrataXRT and 2) standard of care. The incidence of grade ≥ 2 radiation dermatitis, the time to onset of grade ≥ 2 radiation ...
What is the current status of trial NCT05810194?
This trial is currently completed. The enrollment target is 344 participants. The study started on 2023-05-01. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05810194?
The interventions under investigation include: Aquaphor (DRUG), StrataXRT (DEVICE), Calendula (DRUG).
Who is sponsoring clinical trial NCT05810194?
This trial is sponsored by Stratpharma, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.